Chemed Co. (NYSE:CHE) VP Naomi C. Dallob sold 5,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $317.23, for a total transaction of $1,744,765.00. Following the completion of the transaction, the vice president now directly owns 11,122 shares in the company, valued at $3,528,232.06. The transaction was disclosed in a document filed with the SEC, which is available through this link.
CHE traded up $8.42 during trading on Wednesday, reaching $322.11. The company’s stock had a trading volume of 2,211 shares, compared to its average volume of 96,252. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.14 and a quick ratio of 1.11. Chemed Co. has a 1 year low of $227.14 and a 1 year high of $335.99. The firm has a market capitalization of $4.94 billion, a price-to-earnings ratio of 60.02, a price-to-earnings-growth ratio of 2.69 and a beta of 1.23.
Chemed (NYSE:CHE) last released its earnings results on Monday, October 29th. The company reported $3.07 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.80 by $0.27. The business had revenue of $444.15 million for the quarter, compared to analyst estimates of $445.16 million. Chemed had a net margin of 11.73% and a return on equity of 35.13%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company posted $2.15 EPS. On average, equities analysts anticipate that Chemed Co. will post 11.41 earnings per share for the current fiscal year.
A number of research analysts have weighed in on the stock. Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $350.00 target price on the stock in a research note on Tuesday, July 31st. ValuEngine lowered shares of Chemed from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 2nd. Royal Bank of Canada raised their target price on shares of Chemed to $321.00 and gave the stock a “market perform” rating in a research note on Monday, July 30th. Finally, Bank of America assumed coverage on shares of Chemed in a research note on Friday, October 12th. They issued a “buy” rating and a $390.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $334.00.
Several hedge funds have recently added to or reduced their stakes in CHE. LPL Financial LLC purchased a new stake in shares of Chemed during the 1st quarter valued at approximately $236,000. Principal Financial Group Inc. raised its position in shares of Chemed by 3.7% during the 1st quarter. Principal Financial Group Inc. now owns 133,004 shares of the company’s stock valued at $36,291,000 after buying an additional 4,689 shares during the period. Allianz Asset Management GmbH raised its position in shares of Chemed by 7.5% during the 1st quarter. Allianz Asset Management GmbH now owns 2,783 shares of the company’s stock valued at $759,000 after buying an additional 195 shares during the period. Suntrust Banks Inc. raised its position in shares of Chemed by 10.7% during the 1st quarter. Suntrust Banks Inc. now owns 1,723 shares of the company’s stock valued at $469,000 after buying an additional 166 shares during the period. Finally, Xact Kapitalforvaltning AB raised its position in shares of Chemed by 35.2% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 3,072 shares of the company’s stock valued at $989,000 after buying an additional 800 shares during the period. 90.39% of the stock is currently owned by hedge funds and other institutional investors.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Featured Article: Market Capitalization
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.